Cara L. Haymaker

Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center

Affiliated withUniversity of Texas MD Anderson Cancer Center University of Texas MD Anderson Cancer Center

Research Area

Biography

Cara L. Haymaker has not added Biography.
If you are Cara L. Haymaker and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 4	2017
Publication title	2022

Other Publications

Article	Year
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set. BMC medicine\| PubMed ID: 27776519	2016
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade. Cancer immunology research\| PubMed ID: 28062513	2017
4-1BB-Enhanced Expansion of CD8(+) TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8(+) T Cells. Cancer immunology research\| PubMed ID: 28473315	2017
Multifaceted Role of BTLA in the Control of CD8(+) T-cell Fate after Antigen Encounter. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 28754817	2017
4-1BB Agonist Focuses CD8(+) Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 28947567	2017
Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in -Mutant Melanoma. JCO precision oncology\| PubMed ID: 30094412	2018
Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy. Cancer immunology, immunotherapy : CII\| PubMed ID: 31602489	2019
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofi... Journal for immunotherapy of cancer\| PubMed ID: 32350118	2020
Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 32619781	2020
T-cell agonists in cancer immunotherapy. Journal for immunotherapy of cancer\| PubMed ID: 33020242	2020
Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma. The Annals of thoracic surgery\| PubMed ID: 33971174	2022
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. Journal for immunotherapy of cancer\| PubMed ID: 34021033	2021
Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility. Journal of surgical oncology\| PubMed ID: 34057733	2021
Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 34426439	2021
Engineered T-cell Receptor T Cells for Cancer Immunotherapy. Cancer immunology research\| PubMed ID: 34728535	2021
Effector memory cytotoxic CD3/CD8/CD45RO T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc\| PubMed ID: 34839351	2021
Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Gastroenterology\| PubMed ID: 34973294	2022
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 35038676	2022
Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes. Journal for immunotherapy of cancer\| PubMed ID: 35110355	2022
Hallmarks of Resistance to Immune-Checkpoint Inhibitors. Cancer immunology research\| PubMed ID: 35362046	2022